UNIGENE LABORATORIES INC Proceeds from Stock Options Exercised
UNIGENE LABORATORIES INC reported Proceeds from Stock Options Exercised of $13.11 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2013-05-14
- UNIGENE LABORATORIES INC proceeds from stock options exercised for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for the quarter ending 2012-09-30 was $13.00K, a 90.08% decline year-over-year.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for the quarter ending 2012-06-30 was $0.00.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for the quarter ending 2012-03-31 was $13.11K.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for fiscal 2012 was $13.11K, a 96.88% decline from fiscal 2011.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for fiscal 2011 was $420.42K, a 473.19% increase from fiscal 2010.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for fiscal 2010 was $73.35K, a 77.84% decline from fiscal 2009.
- UNIGENE LABORATORIES INC proceeds from stock options exercised for fiscal 2009 was $330.94K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $13.00K derived: sum of 2 quarters · filed 2013-03-15 | $13.00K derived: sum of 3 quarters · filed 2013-03-15 | $13.11K 10-K · filed 2013-03-15 |
| 2012-09-30 | $13.00K 10-Q · filed 2013-01-31 | $13.00K derived: sum of 2 quarters · filed 2013-01-31 | $13.11K 10-Q · filed 2013-01-31 | $261.11K derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-01-31 | $13.11K 10-Q/A · filed 2013-01-31 | $248.11K derived: sum of 3 quarters · filed 2013-05-14 | $379.11K derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | $13.11K 10-Q · filed 2013-05-14 | $248.11K derived: sum of 2 quarters · filed 2013-05-14 | $379.11K derived: sum of 3 quarters · filed 2013-05-14 | |
| 2011-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $366.00K derived: sum of 2 quarters · filed 2013-03-15 | $420.42K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $131.00K 10-Q · filed 2013-01-31 | $185.42K 10-Q · filed 2013-01-31 | ||
| 2011-06-30 | $53.52K 10-Q/A · filed 2013-01-31 | |||
| 2010-12-31 | $70.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $71.91K derived: sum of 2 quarters · filed 2013-03-15 | $73.35K 10-K · filed 2013-03-15 | |
| 2010-09-30 | $1.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $2.85K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $1.43K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $330.94K 10-K/A · filed 2013-01-31 |